SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 140 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2018. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $7,000 | -96.4% | 80,500 | -18.7% | 0.00% | -100.0% |
| Q3 2018 | $192,000 | +13.6% | 99,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $169,000 | -3.4% | 99,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $175,000 | -42.1% | 99,000 | -2.0% | 0.00% | -50.0% |
| Q4 2017 | $302,000 | 0.0% | 101,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $302,000 | -31.4% | 101,000 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $440,000 | -6.6% | 101,000 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $471,000 | -27.3% | 101,000 | -7.8% | 0.00% | -42.9% |
| Q4 2016 | $648,000 | +20.9% | 109,500 | +8.4% | 0.01% | +16.7% |
| Q3 2016 | $536,000 | +41.8% | 101,000 | 0.0% | 0.01% | +50.0% |
| Q2 2016 | $378,000 | +118.5% | 101,000 | +59.1% | 0.00% | +100.0% |
| Q1 2016 | $173,000 | -46.6% | 63,500 | +11.4% | 0.00% | -50.0% |
| Q4 2015 | $324,000 | +8.4% | 57,000 | +0.9% | 0.00% | 0.0% |
| Q3 2015 | $299,000 | -23.1% | 56,500 | +20.2% | 0.00% | -20.0% |
| Q2 2015 | $389,000 | +85.2% | 47,000 | +3.3% | 0.01% | +66.7% |
| Q1 2015 | $210,000 | +32.9% | 45,500 | -10.8% | 0.00% | +50.0% |
| Q4 2014 | $158,000 | +2.6% | 51,000 | -8.1% | 0.00% | 0.0% |
| Q3 2014 | $154,000 | -29.4% | 55,500 | +3.7% | 0.00% | -33.3% |
| Q2 2014 | $218,000 | -25.3% | 53,500 | -2.7% | 0.00% | -40.0% |
| Q1 2014 | $292,000 | +0.7% | 55,000 | +6.8% | 0.01% | 0.0% |
| Q4 2013 | $290,000 | +25.5% | 51,500 | +2.0% | 0.01% | +25.0% |
| Q3 2013 | $231,000 | – | 50,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|